Navigation Links
Exiqon Announces New Grant Program for MicroRNA Research

Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today announced the launch of a new research grant program, open to researchers from academic and non-profit institutions across North America.

(PRWEB) May 15, 2009 -- Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today announced the launch of a new research grant program, open to researchers from academic and non-profit institutions across North America.

"We are excited to offer this type of financial support to the research community at-large. Scientists are making ground-breaking discoveries in the field of microRNA research every day, with implications for human medicine in the form of new insights, new therapies and new diagnostics. Now, more than ever, we recommit ourselves to the success of our customers," says Erik Holmlin, Chief Commercial Officer, Exiqon A/S.

The Exiqon Grant Program has been established with an internal seed funding of $25,000, from which awards will be given to researchers to drive projects enhancing the understanding of how microRNA expression and function relates to normal cellular development, and/or disease-related cellular pathways.

Recipients may use Exiqon Grant Program awards for the purchase of any Exiqon microRNA product or service. Exiqon offers a complete product line for microRNA investigation, including products for RNA isolation, Microarray analysis, qRT-PCR analysis, Northern Blotting, In Situ Hybridization, and Knockdown studies. Exiqon also offers microRNA profiling services for both microarray and qRT-PCR analysis, complete with full sample QC and customized data analysis and reporting.

Researchers are invited to submit an abstract, outlining their research area, project goals, and proposed workflow no later than Monday, June 15th, 2009. Award conveyance through the Exiqon Grant Program does not influence, and is not influenced by, any other existing or potential sources of project funding.

Applications are due June 15th, 2009, and may be submitted electronically via a special Grant Program webpage, Grant recipients will be announced no later than July 1st, 2009.

Chris Harbert
Exiqon, Inc.
888 647 2879


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO
2. BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
3. Standard & Poors Announces Changes to U.S. Index
4. WuXi PharmaTech Announces First-Quarter 2009 Results
5. MAP Pharmaceuticals Announces Presentations at the American Thoracic Society International Conference
6. Select Medical Corporation Announces Results for First Quarter Ended March 31, 2009
7. Human Pheromone Sciences Announces First Quarter Results
8. CorVel Announces Fiscal Year Earnings Release Webcast
9. Robert F. Kennedy, Jr. Announces New Food Allergy Initiative Advocacy Steering Committee
10. UTSA announces funding for new faculty research
11. Nektar Announces UCBs Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
Post Your Comments:
Related Image:
Exiqon Announces New Grant Program for MicroRNA Research
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical Center ... and is the only hospital in the region providing what is known as ... transcatheter pacing patients were revealed recently at a medical conference and published in ...
(Date:12/1/2015)... MD (PRWEB) , ... December 01, 2015 , ... ... salmon identification tests to continue the expansion of the company’s growing product line ... – for Chinook (Oncorhynchus tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... Health Center of Excellence (BHCOE) today announced that the organization has awarded Education ... San Francisco, with a Distinguished Award. The award celebrates exceptional special needs providers ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... for Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or ... anticipated results, once a deal is signed. This quick-read guidance suggests that ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... During the recent 2015 Transcatheter Cardiovascular ... CA , Medinol Ltd. continued to introduce ... a satellite symposium, "The BioNIR eDES: The Role ... a renowned physician panel discussed the key attributes ... Stent System and the Medinol eDES Coronary Stent ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
Breaking Medicine Technology: